Accumulation of prion protein in the brain that is not associated with transmissible disease

Pedro Piccardo1, Jean C Manson, Declan King

  • 1Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA.

Insights

Prion diseases involve prion protein (PrP) accumulation. This study found that PrP amyloid plaques in familial prion disease do not always indicate infectivity or cause spongiform encephalopathy.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Prion diseases, or transmissible spongiform encephalopathies, are characterized by prion protein (PrP) accumulation, with pathological PrP isoforms (PrPSc) serving as diagnostic markers.
  • The relationship between specific PrP forms and infectivity remains unclear, necessitating further investigation into their roles in disease pathogenesis.

Purpose of the Study:

  • To investigate the association between different forms of prion protein (PrP) accumulation and infectivity in familial prion disease.
  • To determine if PrP amyloid deposition is a reliable indicator of transmissible spongiform encephalopathy infectivity.

Main Methods:

  • Bioassays were conducted using human brain extracts from two distinct familial Gerstmann-Sträussler-Scheinker P102L prion disease cases.
  • Transgenic mice (Tg PrP101LL) were inoculated with brain tissue, and disease transmission, spongiform degeneration, and PrP deposition patterns were analyzed.

Main Results:

  • Tissue from a case with spongiform degeneration efficiently transmitted disease to mice, causing spongiform encephalopathy.
  • Tissue from a case without spongiform degeneration showed minimal disease transmission but significant PrP-amyloid deposition in recipient mice.
  • Subsequent passages in mice confirmed the absence of neurological disease transmission from the amyloid-depositing tissue, despite persistent PrP-amyloid accumulation.

Conclusions:

  • PrP amyloidogenesis may occur independently of spongiform encephalopathy and prion disease infectivity.
  • PrP amyloid deposition might not be a reliable marker for transmissible spongiform encephalopathy infectivity.
  • An infectious agent could promote amyloid formation without causing disease, or be sequestered within plaques, rendering it non-pathogenic.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.